At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 66 enrolled
Drug / intervention
Barium Sulfate +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Comparison of VoLumen and Breeza Oral Contrast Agents in Pediatric Patients Undergoing CT and MR Enterography
Children's Hospital Medical Center, Cincinnati·interventional·Posted Oct 27, 2016·Updated Feb 13, 2018
In Brief
A Phase 4 clinical trial evaluating Barium Sulfate and Flavored beverage Oral Contrast for Inflammatory Bowel Diseases. Completed, enrolled 66 participants across 1 site.
Detailed Summary
In this research study, two different oral contrast materials that can be used for CT or MR enterography will be studied. This study is designed to compare which oral contrast material (VoLumen or Breeza) is preferred by pediatric patients and which provides higher quality exams.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInflammatory Bowel Diseases
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedOct 2016
Enrollment StartNov 2016
Primary CompletionNov 2017
TodayJul 2026
First PostedOct 27, 2016
Enrollment StartNov 1, 2016
Primary CompletionNov 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 9.7 years ago
Interventions
Barium Sulfateother
Barium Sulfate Oral Contrast-VoLumen
Flavored beverage Oral Contrastother
Flavored beverage for neutral abdominal/pelvic imaging